Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Indiana for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Indiana only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Indiana (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Optum Pharmacy 702, LLC (NPI 1083045140)

Field	Value
Entity Type	Organization
Organization	Optum Pharmacy 702, LLC
Address	1050 Patrol Rd
City	Jeffersonville
State	IN
ZIP	47130
Taxonomy	Community/Retail Pharmacy
NPI Enumerated	November 27, 2013

Payer Source	Total Paid
Medicaid	$55.1M
Medicare	$0

Key Findings

This provider is effectively single‑payer in scope: there is no Medicare billing on file while lifetime Medicaid revenue totals $55.1M, indicating Medicaid accounts for the entirety of recorded programmatic revenue. Analysts should treat OPTUM PHARMACY 702, LLC as a Medicaid-focused billing entity rather than a mixed Medicare/Medicaid operator.

Revenue is highly concentrated: the precomputed top three Medicaid codes account for 57.6% of this provider's total Medicaid revenue. Those top drivers are J0585 with $20.5M (37.2% of Medicaid revenue), Q9992 with $5.9M (10.7%), and J1726 with $5.3M (9.7%), so a small set of codes dominates the financial picture.

The code mix implies a specialty injectable dispensing model rather than a typical retail pharmacy footprint; large shares come from high-cost, clinic‑administered or long‑acting injectable therapies. Key codes include J0585 (onabotulinumtoxina), Q9992/Q9991 (buprenorphine extended‑release, Sublocade), J1726 (hydroxyprogesterone caproate, Makena) and multiple biologic monoclonal antibodies such as J2357 (omalizumab) and J2323 (natalizumab), consistent with operations that handle specialty biologics, depot addiction treatments, and obstetric prophylaxis.

OPTUM PHARMACY 702, LLC is a dominant statewide supplier for several high‑value codes: J0585 ranks #1 of 26 providers in‑state at the 100th percentile and is labeled an extreme outlier, and the provider also ranks #1 for Q9992 (1 of 2 providers, 100th percentile) and J1726 (1 of 1 providers). For multiple other high‑cost agents (J2357, J2315, J2323, J2182) the provider similarly ranks #1 in‑state, indicating it is a major competitive player for specialty injectable therapies within Indiana.

Several codes show extreme per‑claim or per‑unit cost exposure, which shapes reimbursement and inventory risk: examples include J1726 with $2291 avg paid/claim, J2323 with $5591 avg paid/claim, and J2357 with $2128 avg paid/claim. This pattern signals dependence on relatively few, high‑cost therapies where reimbursement adequacy and supply management materially affect revenue realization.

The file flags specific statistical labels that clarify where the provider is anomalous versus typical peers: J0585 is an extreme outlier (far above typical state volume for this code), J2315 (naltrexone depot) is described as notably above typical state volume, while several other top codes (e.g., Q9992, J2357, J2182) are called typical or unremarkable despite #1 statewide rank. These labels should guide benchmarking comparisons and outlier investigations rather than relying solely on rank.

The clinical breadth of billed therapies spans multiple therapeutic areas — neuromuscular aesthetic/therapeutic injections (J0585), opioid use disorder depot therapies (Q9992/Q9991, J2315), obstetric prophylaxis (J1726), severe asthma and immunology biologics (J2357, J2182, J0517, J2356), and immunomodulators for neurology (J2323). This cross‑therapeutic portfolio suggests the provider supports diverse specialty medication programs rather than focusing on a single disease state.

Tenure is established: the NPI was enumerated on 2013-11-27 (approximately 13 years ago), which provides a defined operating history for trend analysis and supports longitudinal review of how its Medicaid specialty volumes and code mix evolved over time.

Medicaid: Complete Services Breakdown

Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.

21 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0585	Injection, onabotulinumtoxina, 1 unit	16,400	$1,250	$20.5M
Q9992	Injection, buprenorphine extended-release (sublocade), greater than 100 mg	4,160	$1,420	$5.9M
J1726	Injection, hydroxyprogesterone caproate, (makena), 10 mg	2,320	$2,290	$5.3M
J2357	Injection, omalizumab, 5 mg	2,330	$2,130	$5M
Q9991	Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg	3,360	$1,460	$4.9M
J2315	Injection, naltrexone, depot form, 1 mg	3,410	$1,300	$4.4M
J2323	Injection, natalizumab, 1 mg	360	$5,590	$2M
J2182	Injection, mepolizumab, 1 mg	830	$2,390	$2M
J0517	Injection, benralizumab, 1 mg	390	$4,360	$1.7M
J7323	Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose	910	$1,140	$1M

Showing 1–10 of 21

Medicaid: Competitive Analysis & Benchmarks

How this provider's Medicaid billing volume and revenue compare to other Indiana providers billing the same CPT/HCPCS codes.

Claims Volume vs. Indiana Distribution

Optum Pharmacy 702, LLC — 8 of 20 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Indiana

Full comparison — all codes billed, vs. Indiana median

21 rows

CPT/HCPCS Code	Description	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J1726	Injection, hydroxyprogesterone caproate, (makena), 10 mg	1	10	2,320	$2,290	$5.3M
Q9991	Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg	1	10	3,360	$1,460	$4.9M
Q9992	Injection, buprenorphine extended-release (sublocade), greater than 100 mg	1	10	2,100	$1,410	$3M
J0517	Injection, benralizumab, 1 mg	1	10	390	$4,360	$1.7M
J2357	Injection, omalizumab, 5 mg	1	10	1,400	$1,420	$1.6M
J2182	Injection, mepolizumab, 1 mg	1	10	530	$2,210	$1.2M
J2323	Injection, natalizumab, 1 mg	1	10	360	$4,130	$1.1M
J0585	Injection, onabotulinumtoxina, 1 unit	1	30	280	$820	$992.2K
J7318	Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg	1	10	660	$1,190	$785.5K
J2315	Injection, naltrexone, depot form, 1 mg	1	10	350	$910	$775K

Showing 1–10 of 21

Nearby Providers

Other providers in the same ZIP code as Optum Pharmacy 702, LLC, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Lifespring, Inc	IN	Community/Behavioral Health Agency	$0	$53.5M
Maxim Healthcare Services, Inc.	IN	Home Health Agency	$0	$30.1M
Lifespring, Inc	IN	Community/Behavioral Health Agency	$0	$21.6M
Norton Clark Hospital, LLC	IN	General Acute Care Hospital	$0	$19.7M
North Clark Medical Group LLC	IN	General Practice Physician	$0	$16.1M
Pediatric Plus Home Healthcare Services LLC	IN	Home Health Agency	$0	$8.3M
Pax Riverbend LLC	IN	Substance Use Disorder Rehabilitation Clinic/Center	$0	$8M
Utica Township Volunteer Fire Fighters Association	IN	Land Ambulance	$1.6M	$4.9M
Eye Associates Of Southern Indiana PC	IN	Ophthalmology Physician	$0	$6.4M
Kids Dentistry-jeffersonville, LLC	IN	Dental Clinic/Center	$0	$6.4M

Optum Pharmacy 702, LLC — Billing Profile & Reimbursement Data

Sign up for Optum Pharmacy 702, LLC — Billing Profile & Reimbursement Data policy alerts

Optum Pharmacy 702, LLC — Billing Profile & Reimbursement Data

Sign up for Optum Pharmacy 702, LLC — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicaid: Total Revenue Breakdown by CPT/HCPCS Code

Medicaid: Complete Services Breakdown

Medicaid: Competitive Analysis & Benchmarks

Nearby Providers

Frequently Asked Questions

References